F279-0265 Screening compound: ethyl 4-{2-[4-(4-methoxyphenyl)-3-methyl-7-oxo-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-6-yl]butanamido}benzoate

F279-0265 Screening compound: ethyl 4-{2-[4-(4-methoxyphenyl)-3-methyl-7-oxo-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-6-yl]butanamido}benzoate
F279-0265 Screening compound: ethyl 4-{2-[4-(4-methoxyphenyl)-3-methyl-7-oxo-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-6-yl]butanamido}benzoate alternative view

Chemical Structure Depiction of ChemDiv screening compound F279-0265
ethyl 4-{2-[4-(4-methoxyphenyl)-3-methyl-7-oxo-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-6-yl]butanamido}benzoate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F279-0265

Molecular Formula

C26H26N4O6 (C26 H26 N4 O6)

Compound Name

ethyl 4-{2-[4-(4-methoxyphenyl)-3-methyl-7-oxo-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-6-yl]butanamido}benzoate

IUPAC name

ethyl 4-{2-[4-(4-methoxyphenyl)-3-methyl-7-oxo-6H7H-[12]oxazolo[34-d]pyridazin-6-yl]butanamido}benzoate

SMILES

CCC(C(Nc(cc1)ccc1C(OCC)=O)=O)N(C(c1noc(C)c11)=O)N=C1c(cc1)ccc1OC

InChI

InChI=1S/C26H26N4O6/c1-5-20(24(31)27-18-11-7-17(8-12-18)26(33)35-6-2)30-25(32)23-21(15(3)36-29-23)22(28-30)16-9-13-19(34-4)14-10-16/h7-14,20H,5-6H2,1-4H3,(H,27,31)/t20-/m0/s1

InChI Key

HQPYVCDSVQNRBW-FQEVSTJZSA-N

MDL Number (MFCD)

MFCD27111346

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

490.52

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

4.236

Distribution Coefficient, logD

4.236

Water Solubility, LogSw

-4.38

Polar Surface Area

99.296

Acid Dissociation Constant (pKa)

11.07

Base Dissociation Constant (pKb)

0.76

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

26.90

F279-0265 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with F279-0265 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F279-0265?
Check Price and Availability of F279-0265, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F279-0265 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F279-0265
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F279-0265
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F279-0265 available by request